Stratos Wealth Partners, LTD. - INVIVO THERAPEUTICS HLDGS CO ownership

INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M506. A total of 24 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Stratos Wealth Partners, LTD. ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q3 2021$7,0000.0%10,0000.0%0.00%
Q2 2021$7,000
-30.0%
10,000
-0.0%
0.00%
Q1 2021$10,00010,0020.00%
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q4 2021
NameSharesValueWeighting ↓
WEDBUSH SECURITIES INC 81,491$116,0000.01%
NewSquare Capital LLC 62$00.00%
UBS Group AG 6,303$9,0000.00%
Sugarloaf Wealth Management, LLC 1$00.00%
OSAIC HOLDINGS, INC. 32$00.00%
Jacobi Capital Management LLC 1$00.00%
BANK OF AMERICA CORP /DE/ 39$00.00%
FLAGSHIP HARBOR ADVISORS, LLC 1$00.00%
WELLS FARGO & COMPANY/MN 32$00.00%
NORTHERN TRUST CORP 12,751$18,0000.00%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders